Our Business

Market Perspectives

Well Shine Biopolymer is stepping up as a versatile and responsible choice across diverse markets!

MDR Regulation Change

The Medical Device Regulations (MDR) will classify all devices manufactured using tissues or cells of human or animal origin, or their derivatives, which are non-viable or rendered non-viable, as Class III. As Well Shine Biopolymer is of botanical origin, it can help medical device manufacturers to mitigate potential impacts.

Non-Allergen

Shrimp/crab shell-derived chitin/chitosan has a higher risk of causing human allergic reactions. Well Shine Biopolymer is a mild and botanical origin derived Chitin/Chitosan. It is a perfect alternative for replacing shrimp/crab shell-derived chitosan in the medical, textile, cosmetics, and food supplement applications.

Vegetarian Market

Vegetarians do not take shrimp/crab-derived chitosan as a dietary supplement. β-Glucan derived from botanical sources provides a new market opportunity for the vegetarian world.

Skin Care Market

The in-vitro testing of Well Shine® Biopolymer has produced outstanding results. Well Shine Biopolymer was approved by the Personal Care Products Council (PCPC) of the United States and issued the INCI name certificate. The cosmetic industry represents a significant market opportunity for Well Shine Biopolymer.

ESG + Cost Effective

Well Shine Biopolymer is derived from the residue of Ganoderma lucidum extraction. We maximize the use of the cultivated fungal material through our dedicated extraction factory, which integrates the production of both Ganoderma lucidum extract and chitin/chitosan. This allows us to make our products more cost-effective.